Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
Retrieved on:
Thursday, December 22, 2022
Ipca Laboratories, Plasmodium malariae, World Health Organization, Hospital pharmacy, Merck & Co., E-commerce, Inc., Overalls, GlaxoSmithKline, Sun Pharma, Administration, Quinine, Treatment, WHO, Intravenous therapy, Inhalation, Plasmodium falciparum, Growth, Mefloquine, Risk, Ranbaxy Laboratories, Safety, Distribution, Plasmodium knowlesi, Death, Oral, Prevalence, Government, Novartis, Plasmodium vivax, Research, Strides Pharma Science Limited, Plasmodium ovale, Fine chemical, Pharmaceutical industry, Medical device, Dietary supplement, Tutoring, Forecast, Chloroquine, Malaria, Amodiaquine, Hydroxychloroquine, Pyrimethamine, Proguanil
View original content:https://www.prnewswire.com/news-releases/global-antimalarial-drugs-marke...
Key Points:
- Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market.
- Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration.
- • To analyze and forecast the market size of global antimalarial drugs market.
- In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Antimalarial Drugs Market, By Drug Type: